Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Nutex Health (NUTX) Receivables - Net (2016 - 2025)

Nutex Health's Receivables - Net history spans 16 years, with the latest figure at $319.4 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 8768.41% year-over-year to $319.4 million; the TTM value through Dec 2025 reached $319.4 million, up 8768.41%, while the annual FY2025 figure was $319.4 million, 8768.41% up from the prior year.
  • Receivables - Net for Q4 2025 was $319.4 million at Nutex Health, up from $7.3 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $319.4 million in Q4 2025 and bottomed at $334958.0 in Q2 2021.
  • The 5-year median for Receivables - Net is $6.5 million (2025), against an average of $54.1 million.
  • The largest annual shift saw Receivables - Net skyrocketed 28158.42% in 2022 before it plummeted 93.85% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $2.0 million in 2021, then skyrocketed by 2799.98% to $57.8 million in 2022, then increased by 1.38% to $58.6 million in 2023, then tumbled by 93.85% to $3.6 million in 2024, then soared by 8768.41% to $319.4 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Receivables - Net are $319.4 million (Q4 2025), $7.3 million (Q3 2025), and $5.7 million (Q2 2025).